Clinical Trials Browser

Phase 1/2 × Terminated × Advanced Cancers × Clear all

NCT00877773 2016-08-25

Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patients

Phase 1/2 Terminated

44 enrolled 5 charts

Advanced Cancers